Geode Capital Management’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $45.4K | Sell |
26,264
-107
| -0.4% | -$161 | ﹤0.01% | 4223 |
|
|
2026
Q2 | $31.6K | Sell |
26,371
-19,309
| -42% | -$21.4K | ﹤0.01% | 4315 |
|
|
2026
Q1 | $48.4K | Buy |
45,680
+18,174
| +66% | +$36.3K | ﹤0.01% | 4325 |
|
|
2025
Q4 | $50.1K | Buy |
27,506
+6,928
| +34% | +$15.7K | ﹤0.01% | 4232 |
|
|
2025
Q3 | $49K | Buy |
+20,578
| New | +$53.4K | ﹤0.01% | 4300 |
|
|
2025
Q2 | – | Sell |
-4,350
| Closed | -$37.1K | – | 4447 |
|
|
2025
Q1 | $37.1K | Buy |
4,350
+623
| +17% | +$5.71K | ﹤0.01% | 4243 |
|
|
2024
Q4 | $38.9K | Buy |
+3,727
| New | +$47.9K | ﹤0.01% | 4281 |
|
|
2024
Q3 | – | Sell |
-582
| Closed | -$21.2K | – | 4537 |
|
|
2024
Q2 | $21.2K | Hold |
582
| – | – | ﹤0.01% | 4442 |
|
|
2024
Q1 | $52.4K | Hold |
582
| – | – | ﹤0.01% | 4310 |
|
|
2023
Q4 | $48.2K | Buy |
582
+111
| +24% | +$18.2K | ﹤0.01% | 4360 |
|
|
2023
Q3 | $151K | Buy |
471
+53
| +13% | +$25.3K | ﹤0.01% | 4092 |
|
|
2023
Q2 | $287K | Hold |
418
| – | – | ﹤0.01% | 3876 |
|
|
2023
Q1 | $240K | Hold |
418
| – | – | ﹤0.01% | 3952 |
|
|
2022
Q4 | $318K | Buy |
418
+29
| +7% | +$42K | ﹤0.01% | 3858 |
|
|
2022
Q3 | $625K | Buy |
389
+359
| +1,197% | +$493K | ﹤0.01% | 3611 |
|
|
2022
Q2 | $35K | Hold |
30
| – | – | ﹤0.01% | 4852 |
|
|
2022
Q1 | $49K | Buy |
30
+8
| +36% | +$15K | ﹤0.01% | 4806 |
|
|
2021
Q4 | $56K | Buy |
+22
| New | +$68.1K | ﹤0.01% | 4837 |
|
|
2021
Q3 | – | Sell |
-33
| Closed | -$389K | – | 4857 |
|
|
2021
Q2 | $389K | Buy |
+33
| New | +$426K | ﹤0.01% | 4052 |
|
Other funds holding ALZN
Geode Capital Management's ALZN Position: Q3 2026 in Review
Geode Capital Management reduced its Alzamend Neuro (ALZN) stake by 0.41% in Q3 2026, selling an estimated $161 and leaving 26,264 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4223.
Geode Capital Management first reported a position in ALZN in Q2 2021 and has held it in 19 quarters since. The position peaked at $625K in Q3 2022. 5 funds tracked by Wall St. Rank hold ALZN as of Q3 2026.
- Geode Capital Management held 26,264 shares of Alzamend Neuro worth $45.4K as of Q3 2026.
- Geode Capital Management sold 107 Alzamend Neuro shares in Q3 2026, an estimated $161.
- Alzamend Neuro made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4223 holding.
- Geode Capital Management first reported a position in Alzamend Neuro in Q2 2021 and has held it in 19 quarters since.
- Geode Capital Management's Alzamend Neuro position peaked at $625K in Q3 2022.
- 5 funds tracked by Wall St. Rank held Alzamend Neuro as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.